Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist
Systemic Therapy for BCG Unresponsive NMIBC: 1L IO in Cis-Ineligible mUC, Pembro for High-Risk Disease; Toxicity Concerns & QoL
Login to view comments.
Click here to Login